BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33967076)

  • 1. Comparison of irregular flux viewer system with BONENAVI version for identification of Tc-99m MDP whole body bone scan metastasis images.
    Yu CC; Ting CY; Yang MH; Chan HP
    J Xray Sci Technol; 2021; 29(4):617-633. PubMed ID: 33967076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic precision for bone metastasis of primary breast cancer between BONENAVI version 1 and BONENAVI version 2.
    Okada Y; Matsushita S; Nakajima Y; Yamaguchi K; Okuda I; Kojima Y; Tsugawa K
    Nucl Med Commun; 2019 Nov; 40(11):1148-1153. PubMed ID: 31469804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients.
    Koizumi M; Miyaji N; Murata T; Motegi K; Miwa K; Koyama M; Terauchi T; Wagatsuma K; Kawakami K; Richter J
    Ann Nucl Med; 2015 Oct; 29(8):659-65. PubMed ID: 26033528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[
    Sonni I; Minamimoto R; Baratto L; Gambhir SS; Loening AM; Vasanawala SS; Iagaru A
    Mol Imaging Biol; 2020 Apr; 22(2):397-406. PubMed ID: 31236756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting.
    Koizumi M; Wagatsuma K; Miyaji N; Murata T; Miwa K; Takiguchi T; Makino T; Koyama M
    Ann Nucl Med; 2015 Feb; 29(2):138-48. PubMed ID: 25326907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing
    Parihar AS; Schmidt LR; Crandall J; Dehdashti F; Wahl RL
    J Nucl Med; 2023 Mar; 64(3):485-490. PubMed ID: 36265907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of spatially adaptive noise reduction processing in computer-assisted diagnosis system for bone scintigraphy].
    Ichikawa H; Onoguchi M; Okuda K; Kato T; Terabe M; Shimada H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 May; 70(5):461-6. PubMed ID: 24858291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Higashiyama S; Yoshida A; Kawabe J
    Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
    Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate characterization of
    Zhang L; He Q; Zhou T; Zhang B; Li W; Peng H; Zhong X; Ma L; Zhang R
    BMC Med Imaging; 2019 May; 19(1):44. PubMed ID: 31146746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Shintawati R; Achmad A; Higuchi T; Shimada H; Hirasawa H; Arisaka Y; Takahashi A; Nakajima T; Tsushima Y
    Ann Nucl Med; 2015 Dec; 29(10):911-20. PubMed ID: 26373556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients.
    Uslu-Beşli L; Sağer S; Akgün E; Asa S; Şahin OE; Demirdağ Ç; Güner E; Khosroshahi BR; Karayel E; Pehlivanoğlu H; Aygün A; Uslu İ; Talat Z; Sönmezoğlu K
    Turk J Med Sci; 2019 Feb; 49(1):301-310. PubMed ID: 30761859
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Langsteger W; Rezaee A; Pirich C; Beheshti M
    Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
    Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
    Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.